Efficacy and safety of gemigliptin as add‐on therapy to insulin, with or without metformin, in patients with type 2 diabetes mellitus (ZEUS II study)

Author:

Cho Young Min1ORCID,Deerochanawong Chaicharn2ORCID,Seekaew Samroeng3,Suraamornkul Swangjit4,Benjachareonwong Sunun5,Sattanon Sarinya6,Chamnan Parinya7,Sirirak Thanitha8,Kosachunhanun Natapong9,Pratipanawatr Thongchai10,Suwanwalaikorn Sompongse11,Lee Woo Je12ORCID,Kim Sungrae13,Choi Seonghui14,Kang Eun Seok15ORCID,Oh Taekeun16,Kwon Sam17,Lee Moon‐Kyu18ORCID

Affiliation:

1. Department of Internal MedicineSeoul National University College of Medicine Seoul South Korea

2. Diabetes and Endocrinology UnitRajavithi Hospital, Rangsit University College of Medicine Bangkok Thailand

3. Chiangrai Prachanukroh Hospital Chiang Rai Thailand

4. Vajira Hospital, Faculty of MedicineNavamindradhiraj University Bangkok Thailand

5. Police General Hospital Bangkok Thailand

6. Naresuan University Hospital Phitsanulok Thailand

7. Cardiometabolic Research Group, Department of Social MedicineSanpasitthiprasong Hospital Ubon Ratchathani Thailand

8. Department of Family Medicine and Preventive Medicine, Faculty of MedicinePrince of Songkla University Hat Yai, Songkhla Thailand

9. Maharaj Nakorn Chiang Mai Hospital Chiang Mai Thailand

10. Faculty of MedicineKhon Kaen University Khon Kaen Thailand

11. Division of Endocrinology and Metabolism, Department of Medicine, Faculty of MedicineChulalongkorn University Bangkok Thailand

12. Department of Internal MedicineUniversity of Ulsan College of Medicine Seoul South Korea

13. Division of Endocrinology and MetabolismCatholic University of Korea Seoul South Korea

14. Department of MedicineSeoul National University Bundang Hospital, Seoul National University College of Medicine Seoul South Korea

15. Department of Internal MedicineSeverance Hospital, Yonsei University College of Medicine Seoul South Korea

16. Chungbuk National University Hospital, Chungbuk National University College of Medicine Chungbuk Cheongju, South Korea

17. Samsung Changwon Hospital, Sungkyunkwan University School of Medicine Changwon South Korea

18. Division of Endocrinology and Metabolism, Department of MedicineSamsung Medical Center, Sungkyunkwan University School of Medicine Seoul South Korea

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3